- ¥6bn
- ¥20bn
- ¥48bn
- 53
- 86
- 29
- 60
Annual income statement for Care Twentyone, fiscal year end - October 31st, JPY millions except per share, conversion factor applied.
2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | 2025 October 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 36,361 | 38,398 | 41,099 | 45,397 | 48,158 |
| Cost of Revenue | |||||
| Gross Profit | 8,734 | 9,270 | 9,012 | 9,660 | 11,121 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 35,064 | 37,427 | 41,596 | 46,023 | 47,725 |
| Operating Profit | 1,297 | 971 | -497 | -626 | 433 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 1,468 | 1,021 | 108 | 330 | 668 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 939 | 635 | 17 | 276 | 448 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 937 | 630 | 6.16 | 278 | 384 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 937 | 630 | 6.16 | 278 | 384 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 80.9 | 55.2 | 7.24 | 32.7 | 45.5 |
| Dividends per Share |